nei THIS MONTH IN
PSYCHOPHARMACOLOGY
Well-Being, Burnout, and Depression Among North American Psychiatrists
October 28, 2020   

The prevalence of physician burnout is as high as 80.5%, while physician depression may be as high as 28.8%; however, the relationship between burnout and depression among physicians including psychiatrists is not well understood. The current study surveyed psychiatrists online to assess prevalence of burnout and depression, examine the association between burnout and depression, and identify...
 Continue reading (Members only)
Adjunctive Psychotherapy for Bipolar Disorder
October 25, 2020   

Adjunctive psychotherapy is recommended for patients with bipolar disorder; however, the comparative effectiveness of manualized psychotherapies has not been established. Using network meta-analysis...
 Continue reading (Members only)
Universal Hotline Number for the National Suicide Prevention Lifeline to Take Effect in 2022
October 19, 2020   

Beginning in July 2022, Americans experiencing a mental health crisis will be able to dial 9-8-8 and be connected to the services and counselors at the National Suicide Prevention Lifeline....
 Continue reading (Members only)
FDA Committees Vote in Favor of a Combination of Olanzapine and Samidorphan
October 14, 2020   

Two advisory committees, the Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, appointed by the US Food and Drug Administration have voted in favor of ALKS 3831, a combination of olanzapine and samidorphan. The...
 Continue reading
Associations Between Prenatal Cannabis Exposure and Childhood Outcomes
October 13, 2020   

The association between prenatal cannabis exposure and childhood outcomes was recently examined in a longitudinal study, the Adolescent Brain and Cognitive Development (ABCD) study. The results suggest that prenatal cannabis exposure may be associated with...
 Continue reading (Members only)
E-Cigarette Use Tied to Sleep Deprivation in Young Adults
October 11, 2020   

The relationship between e-cigarette use and sleep deprivation was recently examined in a sample of young American adults.The findings suggest that e-cigarette use might be associated with...
 Continue reading (Members only)
Evidence-based Suicide Prevention Strategies During and After the COVID-19 Pandemic
October 5, 2020   

Even before the 2020 COVID-19 pandemic, suicide was a major issue and concern, with approximately 800,000 people dying by suicide each year. Not only has COVID-19 caused an alarming number of deaths due to infection with the SARS-CoV-2 virus, for numerous reasons, the number of lives lost to suicide is also expected to increase because of the COVID-19 pandemic. Due to the economic shutdown and physical distancing measures...
 Continue reading (Members only)
Depression Symptoms Soar During Pandemic, Study Finds
September 28, 2020   

The coronavirus disease 2019 (COVID-19) pandemic has been a traumatic event that is compounded by the policies enacted to prevent its spread, which have introduced new life stressors and disrupted daily living for most people in the United States (US). Early evidence suggests that...
 Continue reading (Members only)
FDA Requiring Stronger Warning Label For Benzodiazepines
September 25, 2020   

The US Food and Drug Administration has ordered changes to the labeling for benzodiazepines, requiring them to include information on the risks of abuse, misuse, addiction, physical dependence, and withdrawal reactions. Benzodiazepines are...
 Continue reading
Prevalence and Risk Factors Associated With Attention-Deficit/Hyperactivity Disorder Among US Black Individuals
September 24, 2020   

The worldwide prevalence of attention deficit/hyperactivity disorder (ADHD) is estimated to be 5.6%-7.2%. Prevalence rates of ADHD among Black individuals are reported to be lower than the rates of the general population. However, there is a paucity of primary studies with appropriate methodological design...
 Continue reading (Members only)
12345678910...
Top of Page